Search

everythinglearnresearchcommunity

for

Search:↓

Some leukemia treatments can cause skin reactions similar to keratosis pilaris.

Abnormal activation of hair follicle stem cells and Wnt/β-catenin signaling contributes to sebaceous neoplasms.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

Early advanced therapies are crucial for better survival in aggressive insulinoma cases.

Mitochondrial genes help predict breast cancer outcomes and spread.

Tangent screens help detect visual field defects from vigabatrin.

Overexpression of certain genes can shorten hair by disrupting the hair-growth cycle.

Promising cancer treatments were found, but the manufacturer closed.

MITF+ melanoma patients are more likely to have multiple melanomas and unique skin patterns.

Reporter characteristics affect detection of hair loss from cancer therapy.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

Overexpressing PKCepsilon in mice reduces papillomas but increases carcinomas.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Cigarette smoke condensates increase tumor-promoting markers in mouse skin, especially around hair follicles.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Senescent melanocytes can boost hair growth by activating hair stem cells.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Bone marrow and hair follicle cells help form skin tumors, suggesting new treatment targets.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Nanocarriers can improve skin treatments after cancer therapy by enhancing antioxidant delivery and effectiveness.

Transplant patients face higher skin cancer risks due to immunosuppressive therapy, requiring careful skin health monitoring.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Permanent hair loss from chemotherapy significantly impacts patients' mental health and social life, highlighting the need for better patient education and support.

The PML protein helps prevent skin cancer in mice.

Dermoscopy can help assess the severity of chronic radiation-induced skin damage in head and neck cancer patients.